Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $5.0900 (0.39%) ($4.9000 - $5.1500) on Mon. Nov. 5, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.49% (three month average) | RSI | 36 | Latest Price | $5.0900(0.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 3.2% a day on average for past five trading days. | Weekly Trend | TGTX declines -6.1% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Rotation from growth to value for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XLRE(8%) GDX(6%) SPLV(6%) XLP(6%) IBB(5%) | Factors Impacting TGTX price | TGTX will decline at least -3.245% in a week (0% probabilities). GDXJ(-4%) DIA(-4%) BNDX(-4%) IFRA(-3%) DRIV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -3.245% (StdDev 6.49%) | Hourly BBV | 0 () | Intraday Trend | -0.2% | | | |
|
1 - 5 Day Possible Target | $-9.36(-283.89%) | Resistance Level | $5.17 | 5 Day Moving Average | $4.83(5.38%) | 10 Day Moving Average | $4.85(4.95%) | 20 Day Moving Average | $5.17(-1.55%) | To recent high | -59.9% | To recent low | 0.4% | Market Cap | $645m | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |